{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:42:10Z","timestamp":1771461730893,"version":"3.50.1"},"reference-count":11,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2018,12,31]],"date-time":"2018-12-31T00:00:00Z","timestamp":1546214400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2018,12,31]],"date-time":"2018-12-31T00:00:00Z","timestamp":1546214400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Hepatology"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1002\/hep.30309","type":"journal-article","created":{"date-parts":[[2018,10,10]],"date-time":"2018-10-10T18:56:57Z","timestamp":1539197817000},"page":"476-479","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":19,"title":["Is This the Last Requiem for Simtuzumab?"],"prefix":"10.1097","volume":"69","author":[{"given":"Peter","family":"Fickert","sequence":"first","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Department of Medicine,Medical University Graz,Graz,Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2018,12,31]]},"reference":[{"key":"hep30309-bib-0001-20241017","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/S1570-9639(03)00053-0","article-title":"Structural and functional diversity of lysyl oxidase and the LOX\u2010like proteins","volume":"1647","year":"2003","journal-title":"Biochim Biophys Acta"},{"key":"hep30309-bib-0002-20241017","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/jcb.10413","article-title":"Lysyl oxidase: properties, specificity, and biological roles inside and outside of the cell","volume":"88","year":"2003","journal-title":"J Cell Biochem"},{"key":"hep30309-bib-0003-20241017","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.3892\/ijmm.2015.2337","article-title":"The function and mechanisms of action of LOXL2 in cancer","volume":"36","year":"2015","journal-title":"Int J Mol Med"},{"key":"hep30309-bib-0004-20241017","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.jhep.2018.04.009","article-title":"Lysyl oxidase\u2010like protein 2 (LOXL2) modulates barrier function in cholangiocytes in cholestasis","volume":"69","year":"2018","journal-title":"J Hepatol"},{"key":"hep30309-bib-0005-20241017","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.jhep.2005.02.052","article-title":"Abnormal deposition of collagen around hepatocytes in Wilson's disease is associated with hepatocyte specific expression of lysyl oxidase and lysyl oxidase like protein\u20102","volume":"43","year":"2005","journal-title":"J Hepatol"},{"key":"hep30309-bib-0006-20241017","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1002\/hep.30237","article-title":"Simtuzumab for primary sclerosing cholangitis: phase 2 study results with insights on the natural history of the disease","volume":"69","year":"2019","journal-title":"Hepatology"},{"key":"hep30309-bib-0007-20241017","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1053\/j.gastro.2018.07.006","article-title":"Simtuzumab is ineffective for patients with bridging fibrosis or compensated cirrhosis caused by nonalcoholic steatohepatitis","volume":"155","year":"2018","journal-title":"Gastroenterology"},{"key":"hep30309-bib-0008-20241017","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S2213-2600(16)30421-0","article-title":"Efficacy of simtuzumab versus placebo in patients with idiopathic pulmonary fibrosis: a randomised, double\u2010blind, controlled, phase 2 trial","volume":"5","year":"2017","journal-title":"Lancet Respir Med"},{"key":"hep30309-bib-0009-20241017","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1136\/gutjnl-2016-312473","article-title":"Selective targeting of lysyl oxidase\u2010like 2 (LOXL2) suppresses hepatic fibrosis progression and accelerates its reversal","volume":"66","year":"2017","journal-title":"Gut"},{"key":"hep30309-bib-0010-20241017","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1634\/theoncologist.2017-0024","article-title":"A phase II randomized, double\u2010blind, placebo\u2010controlled study of simtuzumab or placebo in combination with gemcitabine for the first\u2010line treatment of pancreatic adenocarcinoma","volume":"22","year":"2017","journal-title":"Oncologist"},{"key":"hep30309-bib-0011-20241017","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/0016-5085(95)90220-1","article-title":"Colchicine treatment of primary sclerosing cholangitis","volume":"108","year":"1995","journal-title":"Gastroenterology"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.30309","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/hep.30309","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/hep.30309","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01515467-201902000-00003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T00:10:27Z","timestamp":1729210227000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01515467-201902000-00003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,31]]},"references-count":11,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.30309","relation":{},"ISSN":["0270-9139","1527-3350"],"issn-type":[{"value":"0270-9139","type":"print"},{"value":"1527-3350","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,31]]},"assertion":[{"value":"2018-09-17","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-09-29","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}